WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
FWBI
FIRST WAVE BIOPHARMA INC
$5.75M$2.84$36.001,167.61%Strong Buy1N/AN/AN/AN/A
PMN
PROMIS NEUROSCIENCES INC
$36.39M$1.92N/AN/AN/AN/AN/AN/AN/AN/A
NERV
MINERVA NEUROSCIENCES INC
$16.78M$2.40$11.00358.33%Hold1N/AN/AN/AN/A
VINC
VINCERX PHARMA INC
$19.04M$0.89N/AN/AN/AN/AN/AN/AN/AN/A
ITRM
ITERUM THERAPEUTICS PLC
$26.12M$1.59$6.00277.36%Buy1N/AN/AN/AN/A
CVM
CEL SCI CORP
$71.15M$1.42N/AN/AN/AN/AN/AN/AN/AN/A
PRME
PRIME MEDICINE INC
$632.08M$5.27$17.00222.58%Strong Buy5N/AN/AN/AN/A
ARWR
ARROWHEAD PHARMACEUTICALS INC
$2.87B$23.17$49.40113.21%Buy518.62%N/AN/AN/A
SANA
SANA BIOTECHNOLOGY INC
$2.12B$9.63$13.5040.19%Buy2N/AN/AN/AN/A
WINT
WINDTREE THERAPEUTICS INC
$2.29M$4.49$18.00300.89%Hold1N/AN/AN/AN/A
TELO
TELOMIR PHARMACEUTICALS INC
$202.09M$6.83N/AN/AN/AN/AN/AN/AN/AN/A
RNAZ
TRANSCODE THERAPEUTICS INC
$3.66M$0.63$3.00376.19%Buy1N/AN/AN/AN/A
DYN
DYNE THERAPEUTICS INC
$2.12B$25.83$39.6353.41%Strong Buy8N/AN/AN/AN/A
ERNA
ETERNA THERAPEUTICS INC
$9.63M$1.78N/AN/AN/AN/AN/AN/AN/AN/A
EFTR
EFFECTOR THERAPEUTICS INC
$8.11M$2.20$24.00990.91%Buy1N/AN/AN/AN/A
ABVC
ABVC BIOPHARMA INC
$11.93M$1.13N/AN/AN/AN/AN/AN/AN/AN/A
SER
SERINA THERAPEUTICS INC
$22.26M$8.90N/AN/AN/AN/AN/AN/AN/AN/A
CRBP
CORBUS PHARMACEUTICALS HOLDINGS INC
$390.87M$37.25$52.0039.60%Strong Buy2N/AN/AN/AN/A
AEON
AEON BIOPHARMA INC
$134.91M$3.57$18.00404.20%Buy1N/AN/AN/AN/A
APTO
APTOSE BIOSCIENCES INC
$19.02M$1.21$15.331,167.19%Strong Buy3N/AN/AN/AN/A
KA
KINETA INC
$6.04M$0.55$8.001,351.91%Buy1N/AN/AN/AN/A
ASLN
ASLAN PHARMACEUTICALS LTD
$8.04M$0.46$9.501,978.77%Strong Buy2N/AN/AN/AN/A
NVAX
NOVAVAX INC
$653.58M$4.67$19.00306.85%Buy10.03%N/AN/AN/A
JAGX
JAGUAR HEALTH INC
$62.15M$0.23N/AN/AN/AN/AN/AN/AN/AN/A
ARMP
ARMATA PHARMACEUTICALS INC
$86.76M$2.40$7.00191.67%Buy1N/AN/AN/AN/A
PSTV
PLUS THERAPEUTICS INC
$7.35M$1.72N/AN/AN/AN/A13.89%N/AN/AN/A
ATRA
ATARA BIOTHERAPEUTICS INC
$81.64M$0.68$1.2785.23%Sell3306.09%N/AN/AN/A
ELTX
ELICIO THERAPEUTICS INC
$90.58M$8.85$10.0012.99%Buy1N/AN/AN/AN/A
HCWB
HCW BIOLOGICS INC
$52.08M$1.38N/AN/AN/AN/AN/AN/AN/AN/A
ACXP
ACURX PHARMACEUTICALS INC
$34.04M$2.16$12.00455.56%Buy1N/AN/AN/AN/A
GRTX
GALERA THERAPEUTICS INC
$10.33M$0.19N/AN/AN/AN/AN/AN/AN/AN/A
YS
YS BIOPHARMA CO LTD
$69.79M$0.75$5.25600.00%Buy1N/AN/AN/AN/A
ENGN
ENGENE HOLDINGS INC
$692.51M$15.89$34.40116.49%Strong Buy5N/AN/AN/AN/A
IBIO
IBIO INC
$6.45M$1.85N/AN/AN/AN/AN/AN/AN/AN/A
KPRX
KIORA PHARMACEUTICALS INC
$14.31M$0.55$2.00266.97%Buy1N/AN/AN/AN/A
HUMA
HUMACYTE INC
$523.97M$4.40$7.0059.09%Buy5N/AN/AN/AN/A
DRMA
DERMATA THERAPEUTICS INC
$2.22M$0.33N/AN/AN/AN/AN/AN/AN/AN/A
EPRX
EUPRAXIA PHARMACEUTICALS INC
N/A$2.68N/AN/AN/AN/AN/AN/AN/AN/A
ZVSA
ZYVERSA THERAPEUTICS INC
$3.98M$5.24$240.004,480.15%Buy1N/AN/AN/AN/A
MAIA
MAIA BIOTECHNOLOGY INC
$58.41M$2.92N/AN/AN/AN/AN/AN/AN/AN/A
ICCC
IMMUCELL CORP
$38.75M$5.00N/AN/AN/AN/AN/AN/AN/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$319.50M$6.37$9.6751.76%Strong Buy3N/AN/AN/AN/A
CHRO
CHROMOCELL THERAPEUTICS CORP
$10.40M$1.77N/AN/AN/AN/AN/AN/AN/AN/A
UNCY
UNICYCIVE THERAPEUTICS INC
$39.45M$1.14$5.63395.59%Strong Buy4N/AN/AN/AN/A
ACHV
ACHIEVE LIFE SCIENCES INC
$154.82M$4.52$16.33261.35%Strong Buy3N/AN/AN/AN/A
SLS
SELLAS LIFE SCIENCES GROUP INC
$72.02M$1.28$3.00134.38%Strong Buy1N/AN/AN/AN/A
NRSN
NEUROSENSE THERAPEUTICS LTD
$19.38M$1.26N/AN/AN/AN/AN/AN/AN/AN/A
SKYE
SKYE BIOSCIENCE INC
N/A$12.79$22.5075.92%Strong Buy2N/AN/AN/AN/A
ALLR
ALLARITY THERAPEUTICS INC
$423.26k$1.37N/AN/AN/AN/AN/AN/AN/AN/A
ALZN
ALZAMEND NEURO INC
$4.93M$0.72N/AN/AN/AN/AN/AN/AN/AN/A
CLRB
CELLECTAR BIOSCIENCES INC
$101.94M$3.16$20.00532.91%Strong Buy2N/AN/AN/AN/A
VCNX
VACCINEX INC
$7.39M$6.00N/AN/AN/AN/AN/AN/AN/AN/A
ENSC
ENSYSCE BIOSCIENCES INC
$4.46M$0.61N/AN/AN/AN/AN/AN/AN/AN/A
PTN
PALATIN TECHNOLOGIES INC
$30.18M$1.87$70.003,643.32%Buy1N/AN/AN/AN/A
AKTX
AKARI THERAPEUTICS PLC
$26.94M$1.70N/AN/AN/AN/AN/AN/AN/AN/A
QLGN
QUALIGEN THERAPEUTICS INC
$1.89M$0.30N/AN/AN/AN/AN/AN/AN/A-2,171.48%
BCLI
BRAINSTORM CELL THERAPEUTICS INC
$29.66M$0.43N/AN/AN/AN/AN/AN/AN/AN/A
NRXP
NRX PHARMACEUTICALS INC
$20.86M$2.18N/AN/AN/AN/AN/AN/AN/AN/A
CING
CINGULATE INC
$5.21M$1.04$8.00669.23%Buy1N/AN/AN/AN/A
CNSP
CNS PHARMACEUTICALS INC
$2.32M$0.22N/AN/AN/AN/AN/AN/AN/AN/A
OTLK
OUTLOOK THERAPEUTICS INC
$110.61M$8.50$51.63507.40%Strong Buy7N/AN/AN/AN/A
IVA
INVENTIVA SA
$168.86M$3.24$22.33589.29%Strong Buy3-1.30%N/AN/AN/A
GALT
GALECTIN THERAPEUTICS INC
$216.66M$3.50$11.00214.29%Buy1N/AN/AN/AN/A
KTRA
KINTARA THERAPEUTICS INC
$5.78M$0.15N/AN/AN/AN/AN/AN/AN/AN/A
ONCO
ONCONETIX INC
$2.59M$0.12N/AN/AN/AN/AN/AN/AN/AN/A
OKYO
OKYO PHARMA LTD
$38.33M$1.50$7.00366.67%Buy1N/AN/AN/AN/A
BCTX
BRIACELL THERAPEUTICS CORP
$33.72M$2.11$18.00753.08%Buy1N/AN/AN/AN/A
RNXT
RENOVORX INC
$20.41M$1.21$4.00230.58%Strong Buy1N/AN/AN/AN/A
SCNI
SCINAI IMMUNOTHERAPEUTICS LTD
$1.92M$0.44N/AN/AN/AN/AN/AN/AN/A-1,564.92%
ATNF
180 LIFE SCIENCES CORP
$1.70M$1.99N/AN/AN/AN/AN/AN/AN/AN/A
VTVT
VTV THERAPEUTICS INC
$84.17M$27.96N/AN/AN/AN/AN/AN/AN/AN/A
ANVS
ANNOVIS BIO INC
$67.28M$6.11$21.67254.62%Buy3N/AN/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$91.01M$3.26$18.50467.48%Buy2N/AN/AN/AN/A
CDT
CONDUIT PHARMACEUTICALS INC
$208.20M$2.82N/AN/AN/AN/AN/AN/AN/AN/A
NLSP
NLS PHARMACEUTICS LTD
$4.78M$0.13N/AN/AN/AN/AN/AN/AN/AN/A
ICU
SEASTAR MEDICAL HOLDING CORP
$35.15M$0.47N/AN/AN/AN/AN/AN/AN/AN/A
INKT
MINK THERAPEUTICS INC
$33.07M$0.95$9.00844.39%Buy1N/AN/AN/AN/A
OCEA
OCEAN BIOMEDICAL INC
$51.39M$1.51N/AN/AN/AN/AN/AN/AN/AN/A
NKGN
NKGEN BIOTECH INC
$33.30M$1.46N/AN/AN/AN/AN/AN/AN/AN/A
TVGN
TEVOGEN BIO HOLDINGS INC
$159.68M$0.97N/AN/AN/AN/AN/AN/AN/AN/A
PBM
PSYENCE BIOMEDICAL LTD
$16.07M$1.20N/AN/AN/AN/AN/AN/AN/AN/A
CLDI
CALIDI BIOTHERAPEUTICS INC
$6.86M$0.19$3.251,583.94%Buy2N/AN/AN/AN/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 4.87% over the past year, overperforming other biotech stocks by 26 percentage points.

Corcept Therapeutics has an average 1 year price target of $39.33, an upside of 64.71% from Corcept Therapeutics's current stock price of $23.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.73% over the past year, underperforming other biotech stocks by -9 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 41.52% from Incyte's current stock price of $52.94.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -93.23% over the past year, underperforming other biotech stocks by -72 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 469.95% from Amylyx Pharmaceuticals's current stock price of $1.93.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.06%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.44%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and up 3.18% over the last week. Cytomx Therapeutics was the among the top gainers in the biotechnology industry, gaining 214.72% yesterday.

CytomX Therapeutics shares are trading higher after the company announced that it will report Q1 2024 results and provide an initial CX-904 Phase 1a dose escalation update on May 8, 2024.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.73% in the past year. It has underperformed other stocks in the biotech industry by -9 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.55% in the past year. It has performed in line with other stocks in the biotech industry.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -93.23% in the past year. It has underperformed other stocks in the biotech industry by -72 percentage points.

Are biotech stocks a good buy now?

49.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 84.82% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 7.71x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.